title: Mycobacterium tuberculosis chaperonin 60.1 is a more potent cytokine stimulator than chaperonin 60.2 (Hsp 65) and contains a CD14-binding domain.
abstract: Much attention has focused on the Mycobacterium tuberculosis molecular chaperone chaperonin (Cpn) 60.2 (Hsp 65) in the pathology of tuberculosis because of its immunogenicity and ability to directly activate human monocytes and vascular endothelial cells. However, M. tuberculosis is one of a small group of bacteria that contain multiple genes encoding Cpn 60 proteins. We have now cloned and expressed both M. tuberculosis proteins and report that the novel chaperonin 60, Cpn 60.1, is a more potent inducer of cytokine synthesis than is Cpn 60.2. This is in spite of 76% amino acid sequence similarity between the two mycobacterial chaperonins. The M. tuberculosis Cpn 60.2 protein activates human peripheral blood mononuclear cells by a CD14-independent mechanism, whereas Cpn 60.1 is partially CD14 dependent and contains a peptide sequence whose actions are blocked by anti-CD14 monoclonal antibodies. The cytokine-inducing activity of both chaperonins is extremely resistant to heat. Cpn 60.1 may be an important virulence factor in tuberculosis, able to activate cells by diverse receptor-driven mechanisms.
authors.affiliation: Cellular Microbiology Research Group, Eastman Dental Institute, University College London, London, United Kingdom.
authors.forename: J C
authors.initials: JC
authors.lastname: Lewthwaite
authors.forename: A R
authors.initials: AR
authors.lastname: Coates
authors.forename: P
authors.initials: P
authors.lastname: Tormay
authors.forename: M
authors.initials: M
authors.lastname: Singh
authors.forename: P
authors.initials: P
authors.lastname: Mascagni
authors.forename: S
authors.initials: S
authors.lastname: Poole
authors.forename: M
authors.initials: M
authors.lastname: Roberts
authors.forename: L
authors.initials: L
authors.lastname: Sharp
authors.forename: B
authors.initials: B
authors.lastname: Henderson
mesh_terms: D000595:Amino Acid Sequence; D001426:Bacterial Proteins / Q000737:chemistry / Q000276:immunology*; D001665:Binding Sites; D018834:Chaperonin 60 / Q000276:immunology*; D018833:Chaperonins / Q000737:chemistry / Q000276:immunology*; D016207:Cytokines / Q000096:biosynthesis*; D006801:Humans; D007963:Leukocytes, Mononuclear / Q000276:immunology; D018950:Lipopolysaccharide Receptors; D008070:Lipopolysaccharides / Q000276:immunology; D008969:Molecular Sequence Data; D009169:Mycobacterium tuberculosis; D010455:Peptides / Q000737:chemistry / Q000276:immunology; D011485:Protein Binding; D017433:Protein Structure, Secondary; D017434:Protein Structure, Tertiary; D015398:Signal Transduction
chemical_list: D001426:Bacterial Proteins; D018834:Chaperonin 60; D016207:Cytokines; D018950:Lipopolysaccharide Receptors; D008070:Lipopolysaccharides; D010455:Peptides; C074119:heat-shock protein 65, Mycobacterium; D018833:Chaperonins